Table 1

Hematological parameters, globin and KLF1 genotypes in Thai families with unusual forms of hereditary hemolytic anemia

CasesSexAge (y, mo)Hb (g/dL)Hct (%)RBC (×106/μL)MCV (fL)MCH (pg)MCHC (g/dL)RDW (%)Retic. (%)NRBC (/100WC)Hemoglobin typing (%)Globin genotypesKLF1 genotypes
Hb AHb FHbA2/EHb Portland-1Hb Bart'sαα/ααβ/βAllele 1Allele 2
Family A                     
 P1 4* 3.0 8.5 1.06 80.1 28.1 35.1 16.2 6.0 248 70.1 16.2 3.1 ND ND αα/αα β/β R331W G335R 
6.2 6.9 25.1 2.36 106.2 29.1 27.4 19.0 16.0 1510 38.5 51.8 2.0 
 Father 37 13.4 40.8 4.56 89.5 29.3 32.7 13.3 2.0 82.3 1.5 2.7 αα/αα β/β G335R 
 Mother 34 12.2 37.4 4.69 79.7 26.0 32.6 13.5 1.0 82.5 3.0 2.7 αα/αα β/β R331W 
Family B                     
 P2 0.6 5.9 18.2 2.76 65.9 21.4 32.4 NA 5.0 26 72.3 16.6 8.1§ −SEA/αα βE/β G176RfsX179 R301H 
12 7.5 25.7 3.72 69.1 20.1 29.1 17.8 9.0 181 16.9 39.1 4.3 16.2 14.7 
 Father 36 15.6 46.3 5.88 78.8 26.5 33.6 13.6 0.5 65.1 3.6 2.0 αα/αα β/β R301H 
 Mother 23** 11.4 37 6.41 57.1 17.8 30.9 ND ND 74.9 3.4 21.7 −SEA/αα βE/β G176RfsX179 
 Brother 10 12.5 37.8 5.67 66.7 22.1 33.1 17.4 1.0 54.0 6.9 26.9 αα/αα βE/β G176RfsX179 
Family C                     
 P3 0.2 5.2 19.0 NA 74.0 21.0 28.0 26.0 11.0 124 ND ND ND ND ND αα/αα βE/βE −154C/T A298P 
1.10†† 7.7 24.5 3.35 73.1 23.0 31.4 26.2 14.0 57 21.0 52.8 22.7 
 Father 31 14.0 42.1 5.45 77.3 25.7 33.3 14.5 1.0 68.4 0.5‡‡ 31.1 αα/αα βE/β A298P 
 Mother 32 11.6 35.1 5.0 70.4 23.2 33.0 14.4 0.5 72.0 4.3‡‡ 23.5 αCSα/αα βE/β −154C/T 
Family D                     
 P4 1.2¶¶ 6.5 21.1 2.98 70.6 21.7 30.7 37.1 10.0 100 78.7 5.5 8.3 7.3 0.2 −SEA/-α3.7 βE/β Q58X A298P 
5.4§§ 6.6 21.5 3.09 69.5 21.4 30.9 24.3 5.0 49 70 2.6 9.5 17.6 0.3 
 Father 28 14.0 42.5 6.98 60.9 20.1 32.9 17.2 1.5 75 2.6 22.4 −SEA/αα βE/β Q58X 
 Mother 27 12.1 34.6 4.81 72.0 25.2 35 15.5 1.0 70.2 1.8 28 αα/-α3.7 βE/β A298P 
Family E                     
 P5 18‖‖ 3.4 11.1 1.37 81.0 24.8 30.6 25.4 10.1 113 62.7 29.0 4.6 10.2 6.0 αα/αα β/β G176RfsX179 A298P 
23*** 8.2 27.4 3.38 81.1 24.2 29.9 22.4 6.0 86 
 Father 58 14.4 43.7 5.4 81.0 26.6 33.0 14.6 1.0 82.8 0.9 3.8 −α3.7/αα β/β A298P 
 Mother 55 14.1 42.7 4.85 88.0 29.1 33.1 13.9 1.0 82.8 3.1 2.8 αα/αα β/β G176RfsX179 
Family F                     
 P6 0.9††† 6.6 21.0 2.94 71.0 22.3 31.3 23.8 10.0 33.3 49.8 2.4 13.7 0.8 αCSα/αα β/β G176RfsX179 A298P 
5.7‡‡‡ 8.3 27.1 3.82 70.9 21.6 30.5 23.4 10.0 13 45.0 50.0 3.0 
 Father 34 13.2 40.1 5.5 73.0 24.0 32.9 14.4 6.0 83.0 0.2 2.7 αCSα/αα β/β A298P 
 Mother 30 13.9 41.5 5.2 80.0 26.6 33.5 14.4 2.0 94.8 2.4 2.8 αα/αα β/β G176RfsX179 
 Brother 1 11 11.8 36.7 5.2 70.4 22.7 32.3 15.1 1.0 96.4 0.5 3.1 αCSα/αα β/β G176RfsX179 
 Brother 2 11.7 35.1 4.7 75.4 25.1 33.3 15.1 1.0 94.9 2.4 2.7 αα/αα β/β A298P 
Family G                     
 P7 0.2¶¶¶ 5.7 17.8 2.66 67.0 21.2 31.9 21.9 11.0 146 33.9 54.6 2.2 14.3 0.3 −α3.7/αα β/β G176RfsX179 A298P 
 Mother 22 11.9 36.4 4.59 79 26.0 32.8 14.4 1.0 85.8 2.6 −α3.7/αα β/β G176RfsX179 
Family H                     
 P8 4§§§ 5.4 16.3 2.18 75.0 24.7 33.1 20.4 10 26 69.0 19.0 10.0 αα/αα βE/β G176RfsX179 A298P 
 Father 32 13.5 45.2 5.1 66.0 19.9 29.9 16.1 2.0 95.9 0.9 3.2 −SEA/αα β/β A298P 
 Mother 30 12.7 40.7 5.53 74.0 23.0 31.5 15.1 2.0 66.6 4.7 28.7 αα/αα βE/β G176RfsX179 
CasesSexAge (y, mo)Hb (g/dL)Hct (%)RBC (×106/μL)MCV (fL)MCH (pg)MCHC (g/dL)RDW (%)Retic. (%)NRBC (/100WC)Hemoglobin typing (%)Globin genotypesKLF1 genotypes
Hb AHb FHbA2/EHb Portland-1Hb Bart'sαα/ααβ/βAllele 1Allele 2
Family A                     
 P1 4* 3.0 8.5 1.06 80.1 28.1 35.1 16.2 6.0 248 70.1 16.2 3.1 ND ND αα/αα β/β R331W G335R 
6.2 6.9 25.1 2.36 106.2 29.1 27.4 19.0 16.0 1510 38.5 51.8 2.0 
 Father 37 13.4 40.8 4.56 89.5 29.3 32.7 13.3 2.0 82.3 1.5 2.7 αα/αα β/β G335R 
 Mother 34 12.2 37.4 4.69 79.7 26.0 32.6 13.5 1.0 82.5 3.0 2.7 αα/αα β/β R331W 
Family B                     
 P2 0.6 5.9 18.2 2.76 65.9 21.4 32.4 NA 5.0 26 72.3 16.6 8.1§ −SEA/αα βE/β G176RfsX179 R301H 
12 7.5 25.7 3.72 69.1 20.1 29.1 17.8 9.0 181 16.9 39.1 4.3 16.2 14.7 
 Father 36 15.6 46.3 5.88 78.8 26.5 33.6 13.6 0.5 65.1 3.6 2.0 αα/αα β/β R301H 
 Mother 23** 11.4 37 6.41 57.1 17.8 30.9 ND ND 74.9 3.4 21.7 −SEA/αα βE/β G176RfsX179 
 Brother 10 12.5 37.8 5.67 66.7 22.1 33.1 17.4 1.0 54.0 6.9 26.9 αα/αα βE/β G176RfsX179 
Family C                     
 P3 0.2 5.2 19.0 NA 74.0 21.0 28.0 26.0 11.0 124 ND ND ND ND ND αα/αα βE/βE −154C/T A298P 
1.10†† 7.7 24.5 3.35 73.1 23.0 31.4 26.2 14.0 57 21.0 52.8 22.7 
 Father 31 14.0 42.1 5.45 77.3 25.7 33.3 14.5 1.0 68.4 0.5‡‡ 31.1 αα/αα βE/β A298P 
 Mother 32 11.6 35.1 5.0 70.4 23.2 33.0 14.4 0.5 72.0 4.3‡‡ 23.5 αCSα/αα βE/β −154C/T 
Family D                     
 P4 1.2¶¶ 6.5 21.1 2.98 70.6 21.7 30.7 37.1 10.0 100 78.7 5.5 8.3 7.3 0.2 −SEA/-α3.7 βE/β Q58X A298P 
5.4§§ 6.6 21.5 3.09 69.5 21.4 30.9 24.3 5.0 49 70 2.6 9.5 17.6 0.3 
 Father 28 14.0 42.5 6.98 60.9 20.1 32.9 17.2 1.5 75 2.6 22.4 −SEA/αα βE/β Q58X 
 Mother 27 12.1 34.6 4.81 72.0 25.2 35 15.5 1.0 70.2 1.8 28 αα/-α3.7 βE/β A298P 
Family E                     
 P5 18‖‖ 3.4 11.1 1.37 81.0 24.8 30.6 25.4 10.1 113 62.7 29.0 4.6 10.2 6.0 αα/αα β/β G176RfsX179 A298P 
23*** 8.2 27.4 3.38 81.1 24.2 29.9 22.4 6.0 86 
 Father 58 14.4 43.7 5.4 81.0 26.6 33.0 14.6 1.0 82.8 0.9 3.8 −α3.7/αα β/β A298P 
 Mother 55 14.1 42.7 4.85 88.0 29.1 33.1 13.9 1.0 82.8 3.1 2.8 αα/αα β/β G176RfsX179 
Family F                     
 P6 0.9††† 6.6 21.0 2.94 71.0 22.3 31.3 23.8 10.0 33.3 49.8 2.4 13.7 0.8 αCSα/αα β/β G176RfsX179 A298P 
5.7‡‡‡ 8.3 27.1 3.82 70.9 21.6 30.5 23.4 10.0 13 45.0 50.0 3.0 
 Father 34 13.2 40.1 5.5 73.0 24.0 32.9 14.4 6.0 83.0 0.2 2.7 αCSα/αα β/β A298P 
 Mother 30 13.9 41.5 5.2 80.0 26.6 33.5 14.4 2.0 94.8 2.4 2.8 αα/αα β/β G176RfsX179 
 Brother 1 11 11.8 36.7 5.2 70.4 22.7 32.3 15.1 1.0 96.4 0.5 3.1 αCSα/αα β/β G176RfsX179 
 Brother 2 11.7 35.1 4.7 75.4 25.1 33.3 15.1 1.0 94.9 2.4 2.7 αα/αα β/β A298P 
Family G                     
 P7 0.2¶¶¶ 5.7 17.8 2.66 67.0 21.2 31.9 21.9 11.0 146 33.9 54.6 2.2 14.3 0.3 −α3.7/αα β/β G176RfsX179 A298P 
 Mother 22 11.9 36.4 4.59 79 26.0 32.8 14.4 1.0 85.8 2.6 −α3.7/αα β/β G176RfsX179 
Family H                     
 P8 4§§§ 5.4 16.3 2.18 75.0 24.7 33.1 20.4 10 26 69.0 19.0 10.0 αα/αα βE/β G176RfsX179 A298P 
 Father 32 13.5 45.2 5.1 66.0 19.9 29.9 16.1 2.0 95.9 0.9 3.2 −SEA/αα β/β A298P 
 Mother 30 12.7 40.7 5.53 74.0 23.0 31.5 15.1 2.0 66.6 4.7 28.7 αα/αα βE/β G176RfsX179 

Data of hemoglobin (Hb) analyses showed here derived from liquid chromatography in which HbA2 and Hb E were eluted at the same window and could not separate based on this methodology. Hb Portland-1 (ζ2γ2) and Hb Bart’s (γ4) have not been quantified in every patient (supplemental Table 1 and associated clinical text). Individuals without globin gene mutations are highlighted in gray.

F, female; M, male; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; MCV, mean corpuscular volume; NA, not available; ND, not determined; RDW, red cell distribution width; P, patient; Retic., reticulocyte count; W, wild type for KLF1 gene sequences.

*

This study was done when this patient was first referred to our hospital and 2 months after the last blood transfusion.

This study was performed 1 year after splenectomy and when the patient was free from blood transfusion. Of note, P1 is the only patient with a normal MCH (28 pg), suggesting that the coinheritance of thalassemia makes a significant contribution to the defects in Hb synthesis seen in our patients.

This study was performed when the patient (P2) was first seen at our hospital in 1997 at age 6 months.

The patient received less than 1 month of blood transfusion before this study and has been on regular transfusion since.

§

At first diagnosis, this abnormal hemoglobin was identified as Hb Bart’s.

This study was performed 6 months after splenectomy.

**

The mother of P2 died of lung cancer on February 18, 2004.

††

The patient was withheld from regular blood transfusion for 4 months before this study.

‡‡

HbF measurements were variable even within the same individual; at 2 years before this study, the Hb F levels in the mother and the father were 1.5% and 1.2%, respectively by low-pressure liquid chromatography (LPLC; same laboratory). Moreover, the Hb F levels measured were different based on the techniques used; in the mother, Hb F levels were 4.3%, 3.4%, and 3.3%, and those of the father were 0.5%, 0.9%, and 0%, based on LPLC, high-performance liquid chromatography, and capillary electrophoresis, respectively. Using capillary electrophoresis, we were able to discriminate between Hb E and HbA2; interestingly, the levels of HbA2 in the mother were 3.8% (with 20.8% Hb E) compared with 5.4% (with 26.1% Hb E) in the father. In addition, 0.2% of Hb Constant Spring eluted at retention time 305 s was identified in the mother.

¶¶

This study was done 2 months after blood transfusion, when this patient was first referred.

§§

This study was performed 3 months after the regular blood transfusion was held.

‖‖

This study was performed when this patient was withheld from blood transfusion for 10 weeks.

***

This study was performed 6 months after splenectomy.

†††

This study was performed when this patient first presented at our hospital.

‡‡‡

This study was performed after the patient was free from blood transfusion for 2 years.

¶¶¶

This study was performed when this patient first presented at age 2 months.

§§§

This evaluation was done when the patient was first referred to our center, and the last blood transfusion was performed around 12 weeks before this study.

Close Modal

or Create an Account

Close Modal
Close Modal